169 related articles for article (PubMed ID: 12171303)
21. Characterization of anti-hepatitis C virus-positive sera not genotyped by restriction fragment length polymorphism or serology.
Gish RG; Qian K; Brooks L; Leung J; Xu Y; Pike I; Lau JY
J Gastroenterol Hepatol; 1999 Apr; 14(4):339-44. PubMed ID: 10207783
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
23. GB virus-C infection among chronic haemodialysis patients: clinical implications.
Okuda K; Kanda T; Yokosuka O; Hayashi H; Yokozeki K; Ohtake Y; Irie Y
J Gastroenterol Hepatol; 1997 Nov; 12(11):766-70. PubMed ID: 9430045
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F
Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
26. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt.
Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM
J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis C virus infection among haemodialysis patients.
Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus genotypes in a northeastern area of Brazil.
Silva LK; Paraná R; Souza SP; Berby F; Kay A; Trepó C; Santana N; Cotrim H; Lyra LG; Reis MG
Am J Trop Med Hyg; 2000 Feb; 62(2):257-60. PubMed ID: 10813481
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
30. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
[TBL] [Abstract][Full Text] [Related]
31. Distribution of hepatitis C virus genotypes in haemodialysis patients of Guilan, northern Islamic Republic of Iran.
Joukar F; Khalesi AK; Jafarshad R; Rahimabadi MS; Mansour-Ghanaei F
East Mediterr Health J; 2012 Mar; 18(3):236-40. PubMed ID: 22574476
[TBL] [Abstract][Full Text] [Related]
32. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
[TBL] [Abstract][Full Text] [Related]
34. Presence of different hepatitis C virus genotypes in plasma and peripheral blood mononuclear cell samples of Iranian patients with HIV infection.
Dehghani-Dehej F; Sarvari J; Esghaei M; Hosseini SY; Garshasbi S; Kalantari S; Monavari SH; Fakhim A; Keyvani H; Bokharaei-Salim F
J Med Virol; 2018 Aug; 90(8):1343-1351. PubMed ID: 28845894
[TBL] [Abstract][Full Text] [Related]
35. Rising burden of Hepatitis C Virus in hemodialysis patients.
Khan S; Attaullah S; Ali I; Ayaz S; Naseemullah ; Khan SN; Siraj S; Khan J
Virol J; 2011; 8():438. PubMed ID: 21920054
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and significance of hepatitis C virus (HCV) genotypes in anti-HCV positive patients in northwest Croatia.
Golubić D; Vurusić B; Kessler HH
Acta Med Croatica; 1997; 51(2):79-82. PubMed ID: 9204591
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China.
Su Y; Yan R; Duan Z; Norris JL; Wang L; Jiang Y; Xing W; Chen Y; Xiao Y; Li L; Tao J; Wang N
J Med Virol; 2013 Mar; 85(3):425-32. PubMed ID: 23341370
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection in haemodialysis patients: a clinical and virological study.
Corcoran GD; Brink NS; Millar CG; Garson JA; Waite J; Deaville R; Thompson FD; Tedder RS
J Infect; 1994 May; 28(3):279-85. PubMed ID: 7522261
[TBL] [Abstract][Full Text] [Related]
40. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening.
Irish DN; Blake C; Christophers J; Craske JE; Burnapp L; Abbs IC; MacMahon EM; Muir P; Banatvala JE; Simmonds P
J Med Virol; 1999 Oct; 59(2):135-40. PubMed ID: 10459146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
